Clinical Trials Browser

Not yet recruiting × Idarubicin × 1 year × Clear all

NCT07407140 2026-03-02

VAG-3+7-G

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07223814 2025-11-03

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute